Clinical Trial Update: A Study of Taspoglutide in Type 2 Diabetic Patients [Phase 1]

View source ↗

Summary

A Phase 1 study of Taspoglutide in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED